OGN Organon & Co. Loading... : Bullish and Bearish Analyst Opinions
Loading chart...
Top Calls
Feed
15:42
Aug 09
Aug 09
AOC egg news boosts OGN Follistim demand
Buy OGN as AOC's public egg-freezing announcement raises fertility treatment visibility; Follistim is a key fertility drug and OGN is in acquisition process, giving a near-term catalyst overlay.
MED
18:33
May 15
May 15
SEC FOIA logs reveal ongoing investigations for listed companies.
SEC FOIA logs reveal ongoing investigations for listed companies, indicating regulatory scrutiny but no directional view expressed.
HIGH
00:09
Apr 28
Apr 28
M&A announcement: Sun Pharma to acquire Organon for $11.75B.
M&A announcement: Sun Pharma to acquire Organon for $11.75B. Factual report, no directional view from speaker.
HIGH
00:07
Apr 27
Apr 27
Organon received a takeover bid, validating its depressed valuation.
Organon received a takeover bid, validating its depressed valuation; anticipate price appreciation toward the bid premium.
HIGH
20:23
Apr 10
Apr 10
Organon shares climbed ~28% after a report that Sun Pharmaceutical is set to make a $12B offer, following a prior 8% gain on related speculation. Sun called the report "speculative." The stock's extreme reaction to successive days of M&A speculation indicates the market assigns a high probability to a deal, with reports claiming detailed due diligence has been completed. WATCH due to high, event-driven volatility centered on a potential takeover, where the outcome is binary and dependent on a formal offer materializing. The deal fails to materialize, causing the speculative premium to collapse.
About OGN Analyst Coverage
Buzzberg tracks OGN (Organon & Co.) across 4 sources. 1 bullish vs 0 bearish calls from 4 analysts. Sentiment: predominantly bullish (20%). 5 total trade ideas tracked. Latest voices: BarbarianCap, stockjabber, Jim Cramer.